According to a Manifold Markets prediction, Tesla is expected to announce a formal partnership with Intel for AI chip...
According to a Manifold Markets prediction, Tesla is expected to announce a formal partnership with Intel for AI chip fabrication by June 30, 2026, with a consensus probability of 96.54%. The market's high conviction suggests that a deal is widely anticipated, which would significantly boost Intel's foundry business and potentially shift AI chip supply dynamics. If realized, this partnership could challenge existing foundry relationships and impact competitors like TSMC and NVIDIA. What the sources said: - Manifold Markets: 'Will Tesla announce formal Intel partnership for AI chip fab by June 30, 2026?' Consensus YES=96.54%.
confidence score
Strong evidence: 1 independent source class support this read.
INTC has already moved up +42% over the recent 30-90 day window.
signal brief
According to a Manifold Markets prediction, Tesla is expected to announce a formal partnership with Intel for AI chip fabrication by June 30, 2026, with a consensus probability of 96.54%. The market's high conviction suggests that a deal is widely anticipated, which would significantly boost Intel's foundry business and potentially shift AI chip supply dynamics. If realized, this partnership could challenge existing foundry relationships and impact competitors like TSMC and NVIDIA.
What the sources said:
- Manifold Markets: 'Will Tesla announce formal Intel partnership for AI chip fab by June 30, 2026?' Consensus YES=96.54%.
source data used
“Manifold consensus on 'Will Intel manufacture NVIDIA chips by the end of 2026?': YES=27.00%”
“Manifold consensus on 'Tesla announces formal Intel partnership for AI chip fab by June 30, 2026': YES=96.54%”
“Manifold consensus on 'Will there be a joint venture chip foundry between TSMC and Intel? 🇺🇸🦾🤖💻': YES=48.73%”
“Manifold consensus on 'Will Intel's lithography catch up with TSMC by 2028?': YES=14.03%”
spillover entities
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.